STUDIES ON THE TOLERANCE OF
THE IMMUNE SYSTEM OF MOUSE CHIMERAS. EUR 1220.e by Doria, G.
• t 
REPRINT LIBRARY'. t:OPY 
I 
" 
' . 
,, 
, 
EUROPEAN ATOMIC ENERGY COMMUNITY - EURATOM 
STUDIES ON THE TOLERANCE OF 
; 
I 
·, ,t 
THE IMMUNE SYSTEM OF MOUSE CHIMERAS 
by 
G. ·DORIA 
· (Euratom) 
:@ 
Work performed by the 
Laboratorio di Radioblologia Animate, C.S.N. della Casaccia (Roma), Italy 
Euratom Contract No. 021-63-3 BIOi 
Reprinted from 
.i\NNALS OF THE NEW YORK ACADEMY OF SCIENCES 
Vol. 120, Article J - 1964 
at the Sixth International Transplantation Conference, 
New York Academy of Sciences 
New York - February 6/8, 1964 
" 
. ' 
l 
' , /l II 
..,, 
. . 
p. 
.. 
• .. 
I 
J 
) • 
• 
r 
~ .. 
. ~ 
1 f ~ 
" I 
• 
,'IJ 
• l 
.. 
... 
• ~ . . ,( 
I . . , i 
,, 
. 
., 
k F 11 
, r 
' ,... ' •t. ·~ - . 
Ar ' r.. • 
I, ~ ... • 
I • 
: ... 
t I ~ 
. 
"; 
a 
~ 
LEGAL NOTICE 
J,J t "J. ... 
'!· 
4 ' ; wt}?' i ' ll'; 
.. 
This document was prepared under the sponsorship of the Commission of the European 
Atomic Energy Community (EURA TOM). 
' . ' r . • • 
Neither the EURATOM Commission, its contractors nor any person acting on their behalf: 
1 o - Make any warranty or representation, express or implied, with respect to the accuracy, 
completene~s, or usefulness of the information contained in this document, or that the use 
of any information, apparatus, method, or process disclosed in this document may not 
infringe privately owned rights; or 
20 - Assume any liability with respect to the use of, or for damages resulting from the use of 
any information, apparatus, method or process disclosed in this document . 
t . 
This reprint is intended for restricted distribution only. It reproduces, 
by kind permission of the publisher, an article from "ANNALS OF 
THE NEW YORK ACADEMY OF SCIENCES", Vol. 120, 
Article 1 - 1964; 225-229. : For further copies please apply to Editorial 
Department, The New 1fort Academy of Sciences - 2 East Sixty-third 
Street, New York 21, N.Y. (USA). 
Dieser Sonderdruck ist fur eine beschrii.nkte V erteilung bestimmt. Die 
Wiedergabe des vorliegenden in ,,ANNALS OF THE NEW YORK 
ACADEMY OF SCIENCES", Vol. 120, Article 1 - 1964, 225-229 
erschienenen Aufsatzes erfolgt mit freundlicher Genehmigung des 
Herausgebers. Bestellungen weiterer Exemplare sind an Editorial 
Department, The New York Academy of Sciences - 2 East Sixty-third 
Street, New York 21, N,Y. (USA), zu richten . 
Ce tire-a-part est exclusivement destine a une diffusion restreinte. Il 
reprend, avec l' aimable autorisation de l' editeur, un article publie dans 
<< ANNALS OF THE NEW YORK ACADEMY OF SCIENCES'II, 
Vol. 120, Article 1 - 1964, 225-229. Tout autre exemplaire de cet article 
doit etre demande a Editorial Department, The New York Academy of 
Sciences - 2 East Sixty-third Street, New York 21, N.Y. (USA) . 
~ 
Questo estratto e destinato esclusivamente ad una dif fusione limitata. 
Esso e stato riprod,otto, per gentile concessione 'dell' Editore, da 
«ANNALS OF THE .NEW YORK ACADEMY OF SCIENCES», 
Vol. 120, Article l -196.4, 225-229. UUeriori copie dell'articolo debbono 
essere richieste a Editorial Department, The New York Academy of 
Sciences - 2 East Sixty-third Street, New York 21, N.Y. (USA). 
, , De~e overdruk is ,slechts voor beperkte verspreit!,ing bes!pnd. Hfd, artikel 
is met welwillen4e toefte~mi?'jg '!~n de uitgever overgenomen uit 
,,ANNALS OF THE NEW YORK ACADEMY OF SCIENCES", 
Vol. 120, Article 1 - 1964, 225-229. Meer exemplaren kunnen besteld 
warden bij Editorial Department, The N~'w ,Yark Acade»W of Sciences -
2 East' Sixty-third Street, New York 21, N.Y. (USA). 
... 
.. 
. 
'\, • I' 
•· 
,, 
.. 
.. 
t. 1' \a ' ' • ,1 
I 
•,, 
l I 
Reprinted from Annals of The New York Academy of Sciences 
Volume 120, Article 1, Pages 225-229 
November 30, 19 64 
STUDIES ON THE TOLERANCE OF THE IMMUNE SYSTEM 
OF MOUSE CHIMERAS 
Gino Doria* 
Euratom Biology Division, Atomic Energy Commission of Italy, Casaccia, Italy 
Adult mice made tolerant of skin homografts by neonatal injection of homo-
logous hemopoietic cells, and adult mice lethally x-irradiated and subsequently 
injected with homologous hemopoietic cells are known to be cell chimeras. In-
deed, injection of homologous hemopoietic cells into normal neonatal or irra-
diated adult mice is followed by take and proliferation of the transferred cells. 
Direct evidence for the existence of cell chimerism in tolerant mice was presented 
by Trentin and Sessions,1 who were able to identify donor cells by use of a 
chromosomal marker. In radiation chimeras, the presence of donor cells was 
clearly shown several times and by various techniques.2 
It is generally accepted that the hemopoietic tissues commonly used to induce 
tolerance or to restore lethally irradiated mice, i.e., spleen or bone marrow, con-
tain potential or actual antibody-forming cells. The observation of runt disease 
in tolerant mice of some donor-recipient strain combinations (interpreted as 
being due to a graft-anti-host immune reaction) indicates that immunologically 
competent donor cells can colonize the injected newborns and confer a chimeric 
feature to the developing immune system. Likewise, repopulation of the irradia-
ted host by competent donor cells is admitted to occur in radiation chimeras. The 
appearance of secondary disease in these animals indeed is referred to a graft-
anti-host immune reaction. If the host immune system recovers from radiation 
damage, as might be the case in mice exposed to a 30-day LD100 of X-rays, some 
time after irradiation and hemopoietic treatment the immune system of the ani-
mal should be a mosaic of host and donor cells. Therefore, on the basis of the 
foregoing facts and arguments, immunologically competent cells of host and 
donor types may be expected to coexist in both tolerant mice and radiation 
chimeras. 
Frequency and severity of runt and secondary diseases depend upon the strain 
combinations used. Longevity of the tolerant mice and radiation chimeras that 
escaped or survived runt or secondary disease implies that some time after their 
transplantation the immunologically competent donor cells either have disap-
peared or ceased to react against the host antigens, or never started this reaction. 
Persistence of skin grafts and hemopoietic cells of donor type in tolerant mice 
several months after the neonatal injection indicates that the host immune system 
remains unable to react against antigens of the donor type. Presence of donor 
hemopoietic cells in long-term radiation chimeras suggests that the host immune 
system, if ever recovered from radiation damage, is unreactive against the hemo-
poietic graft. 
The present study is an experimental analysis of the immune system of tolerant 
mice and radiation chimeras several months after the injection of the homologous 
hemopoietic cells. The aim was the identification of host and donor antibody-
forming cells and evaluation of their functional state. 
• Present address: Laboratorio di Radiobiologia Animale, C.S.N. della Casaccia (Roma), 
Italia. 
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Methods and Results 
Agglutinin response to heterologous antigens was induced in tolerant mice 
and radiation chimeras. Their spleen cells were then analyzed in a discriminant 
test to find out whether host or donor cells were responsible for the agglutinins 
produced to the heterologous antigen. Technical details have been published 
elsewhere.3•4 
Tolerant mice. C3H newborn mice of both sexes were injected intravenously 
with 1 X 107 nucleated spleen cells from CBA adult female mice. Two months 
after the neonatal injection, 22 C3H mice were grafted with CBA skin from 
adult donors of the same sex as the recipients. The skin grafts showed no macro-
scopic signs of rejection during the observation time of three months. In contrast, 
CBA skins grafted onto 12 age-control C3H mice, noninjected at birth, showed 
complete necrosis in 11.7 ± 0.4 days. 
That the tolerant mice were chimeras could be inferred from the detection of 
donor type antigens in their spleens. This was performed by injecting spleen 
cells from tolerant mice, at the time of their sacrifice for the identification test 
(see below), into normal C3H mice, which were then tested for transplantation 
immunity against CBA antigens by a method previously described.4 
When five months old, 11 tolerant mice, 10 normal C3H, and 10 normal CBA 
mice were injected intraperitoneally with 1 ml. of one per cent rat RBC. Twelve 
days later, blood was collected individually for serum titration of antirat RBC 
agglutinins. The mean log2 titer of tolerant mice was found normal, that is. not 
significantly different (P = 0.20) from that of normal C3H and CBA mice. 
This result indicates that the unresponsiveness of C3H mice to CBA skin grafts 
was specific, for the tolerant mice were able to respond with normal vigor to an 
antigen unrelated to C3H and CBA strains. 
None. of the tolerant mice showed any sign of runt disease at any time before 
and after the injection of rat RBC. 
Identification of the immune system of tolerant mice. Normal C3H and CBA 
adult mice were immunized by intraperitoneal injection of 1 X 107 nucleated 
spleen cells from adult CBA or C3H mice, respectively, and 10 days later were 
given a total-body X-ray dose of 700 r. Within two hours after the irradiation, 
the immunized mice of each type were divided in four groups of 7 to 15 animals. 
A control group received intravenously 1 ml. of Tyrode's solution. The others 
received intravenously one of the following inocula in 1 ml. volume of Tyrode's 
solution: 24 X 106 nucleated spleen cells from C3H, CBA, or tolerant C3H 
mice. All donor mice had been injected intraperitoneally with 1 ml. of one per 
cent rat RBC 12 days earlier, and each cell suspension was prepared from a pool 
of five to six spleens. Immediately after the intravenous injection, all groups 
were given intraperitoneally 1 ml. of one per cent rat RBC. Six days later, the 
recipients were decapitated, and blood was collected individually for serum titra-
tion of antirat RBC agglutinins. The results are presented in TABLE 1. 
The Table shows that the antirat RBC agglutinins detected in the irradiated 
recipients were produced only by the secondary response of the transferred spleen 
cells. Spleen cells from C3H or CBA donors did not produce agglutinins when 
transferred into irradiated recipients specifically immunized to the spleen cell 
donor. Spleen cells from tolerant C3H mice produced agglutinins when trans-
ferred into irradiated C3H mice immunized to CBA tissues, but did not yield 
agglutinins when transferred into CBA mice immunized to C3H tissues. This 
finding demonstrates that the secondary response of spleen cells from the tolerant 
mice was due only to the C3H cells, that is, to the host cells. 
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TABLE 1 
PRESENCE ( +) OR ABSENCE (0) OF ANTIRAT RBC AGGLUTININS 
IN THE SERUM OF RECIPIENT MICE 
227 
Irradiated recipients Spleen cell donors sensitized to rat RBC 
given rat RBC None C3H CBA Tolerant C3H 
C3H anti CBA 0 + 0 + 
CBA anti C3H 0 0 + 0 
Radiation chimeras. Twelve-week-old male and female (101 X C3H) F1 mice 
were given a total-body X-ray dose of 900 r ( 30-day LD100). Within four hours 
after irradiation, they were injected intravenously with 2 X 107 nucleated bone 
marrow cells from (C57Bl/6 X DBA/2) F1 donors of the same age and sex as 
the recipients. 
Five months after the bone marrow injection, mice that survived secondary 
disease were found to be cell chimeras, for their peripheral blood was shown 
to have donor type cells by the agglutination technique of Gorer and Mikulska. 5 
Twenty of these long-term survivors, 15 normal ( 101 X C3H) F1, and 15 normal 
(C57Bl/6 X DBA/2) F1 mice of the same age as the chimera hosts were in-
jected intraperitoneally with 1 ml. of one per cent rat RBC. Eighteen days later, 
blood was collected for serum titration of antisheep RBC agglutinins. The mean 
log2 titer of the radiation chimeras was found subnormal, that is, significantly 
lower (P = 0.05) than that of the normal mice. 
Identification of the immune system of radiation chimeras. Normal ( 101 X 
C3H) F1 and (C57Bl/6 X DBA/2) F1 adult mice were immunized by intra-
peritoneal injection of 1 X 107 nucleated spleen cells from adult ( C57BI/ 6 X 
DBA/2) F1 or ( 101 X C3H) F 1 mice, respectively, and 18 days later were given 
a total-body X-ray dose of 900 r. Within two hours after the irradiation, the 
immunized mice of each type were divided in four groups of 10 animals. A con-
trol group received intravenously 1 ml. of Tyrode's solution. The others received 
intravenously one of the following inocula in 1 ml. volume of Tyrode's solution: 
12 X 106 nucleated spleen cells from (101 X C3H) F1, (C57Bl/6 X DBA/2) 
F1 mice, or radiation chimeras. All donor mice had been injected intraperitoneally 
with 1 ml. of one per cent sheep RBC 18 days earlier and each cell suspension 
was prepared from a pool of four to five spleens. Immediately after the intra-
venous injection, all groups were given intraperitoneally 1 ml. of one per cent 
sheep RBC. Six days later, the recipients were sacrificed, and blood was collected 
individually for serum titration of antisheep RBC agglutinins. The results are 
given in TABLE 2. 
TABLE 2 
PRESENCE ( + ) OR ABSENCE ( 0) OF ANTISHEEP RBC AGGLUTININS 
IN THE SERUM OF RECIPIENT MICE 
Spleen cell donors sensitized to sheep RBC 
Irradiated recipients (101 X C3H) F1 given sheep RBC None (IOI X C3H) F1 (C5781/6 X DBA/2) F1 chimeras 
(101 X C3H) F 1 anti-
(C57Bl/6 X DBA /2) F, 0 + 0 0 
(C57Bl/6 X DBA/2) F, 
anti-(101 X C3H) F 1 0 0 + + 
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This Table shows that the antisheep RBC agglutinins found in the irradiated 
recipients were produced only by the secondary response of the injected spleen 
cells. Spleen cells from (101 X C3H) F 1 or (C57Bl/6 X DBA/2) F1 donors 
did not produce agglutinins when transferred into irradiated recipients speci-
fically immunized to the spleen cell donor. Spleen cells from radiation chimeras 
produced agglutinins when transferred into irradiated (C57Bl/6 X DBA/2) F 1 
mice immunized to (101 X C3H) F1 tissues, but did not form agglutinins when 
transferred into (101 X C3H) F 1 mice immunized to (C57Bl/6 X DBA/2) F 1 
tissues. This result demonstrates that the secondary response of spleen cells from 
the radiation chimeras was due only to the (C57Bl/6 X DBA/2) F 1 cells, that 
is, to the donor cells. 
Discussion 
In the experiments presented, tolerant mice and radiation chimeras were shown 
by indirect and direct techniques, respectively, to be mosaics of host and donor 
cells. Agglutinin response to heterologous antigens was induced in both types of 
chimeras, and resulted normal in tolerant mice and subnormal in radiation chime-
ras. Their spleen cells were found able to give a secondary agglutinin response 
when transferred into proper recipients and challenged again with the test antigen. 
Only cells of host or donor type where found responsible for the agglutinin pro-
duction by spleen cells transferred from tolerant mice or radiation chimeras, 
respectively. Since the method of identification used was based on a secondary 
agglutinin response, it follows that also the primary response to the heterologous 
antigen should have been produced by host cells in the tolerant mice and by 
donor cells in the radiation chimeras. The nondetectability of immunologic activ-
ity to the heterologous antigen by donor cells in the tolerant mice and by 
host cells in the radiation chimeras implies that the undetected cells either were 
absent at the time of the antigen challenge or incapable of responding to it. Both 
possibilities have been discussed previously.3•4 These negative results raise the 
question of the sensitivity of the method used. Preliminary controls showed that 
in order to detect a secondary agglutinin response against rat RBC in the serum 
of irradiated CBA mice, preimmunized to C3H tissues and given the test antigen, 
at least 5 X 105 spleen cells needed to be transferred from CBA mice sensitized 
against rat RBC. Similarly, a threshold of 7 X 105 spleen cells was found when 
irradiated (101 X C3H) F1 mice preimmunized to (C57Bl/6 X DBA/2) Fi 
tissues were used as recipients and sensitized ( 101 X C3H) F 1 mice, as donors. 
However, it should be pointed out that the sensitivity of the method for detecting 
the immunologic activity of cells grown in chimeric tissues may be different, and, 
therefore, cannot be estimated from these types of controls. While the finding of 
only donor cells being responsible for antibody production in homologous radia-
tion chimeras is in agreement with previous results,2 the lack of donor type im-
mune activity in tolerant mice might seem at variance with what was found by 
Michie et al.6 These authors analyzed the chimerism of the immune system of 
tolerant mice, making use of Simonsen's G.V.H. assay,7 whereby immunologic 
competence of cells is evaluated by measuring their capability to induce spleen 
enlargement when injected into susceptible recipients. They reported that cells 
from mice supposed to be "specifically" tolerant could induce spleen enlargement 
when transplanted into recipient mice carrying antigenic components unrelated 
to the host and donor strains used in the induction of tolerance. In some experi-
ments, the transplanted cells responsible for the spleen enlargement were found 
to be of host type, while in other experiments, of both host and donor types. 
These results would suggest that host and donor type cells, potentially capable 
Doria: Immune System of Mouse Chimeras 229 
of a primary immune response, were both present in some of the tolerant mice. 
However, since their mice had not been tested for the specificity of tolerance, it 
is difficult to predict which type of immune system would actually have responded 
in the tolerant animals, had they been challenged with antigens unrelated to the 
host and donor strains. 
The present findings allow an attempt to evaluate the functional state of the 
immune system of tolerant mice and radiation chimeras. The host immune sys-
tem of tolerant mice, being the only one responsible for the primary agglutinin 
production elicited in these animals by rat RBC, can be considered in a tolerant 
state, for it was capable, while tolerating a homologous skin graft, to respond 
with normal vigor to antigens unrelated to the host and donor strains. In the 
light of this observation, the definition of tolerance (specific unresponsiveness), 
so far referred to the whole animal,8 can also be applied to the host immune 
system. 
Longevity of the radiation chimeras suggests that at the time of the experiment, 
the donor immune system was not reacting against the host antigens. However, 
this unresponsiveness was not specific, for the primary response to sheep RBC 
produced in the chimera by the donor immune system was subnormal. Hence, 
unlike tolerant mice, the radiation chimeras analyzed in the present work had 
an immune system that cannot be considered in a tolerant state. This conclusion 
is in contrast with the claim that the donor immune system of long-term radia-
tion chimeras is ''specifically" unresponsive to the host antigens and, therefore, 
in a tolerant state.9- 11 The specificity of such unresponsiveness was demonstrated 
by the normal response against antigens unrelated to the host and donor strains, 
which was displayed by donor type lymphoid cells when transferred from radia-
tion chimeras to suitable test recipient mice. However, the rate of differentiation 
and proliferation of the immunologically competent cells, which affects the in-
tensity of an immune reaction, may have changed upon their transfer from the 
chimeric tissues to the test recipients. Therefore, a normal degree of response 
by retransplanted donor type cells does not prove that also in the chimera the 
donor type immune system was capable of reacting with normal vigor to the 
test antigen. On the contrary, direct estimate of antibody production in the 
chimeras, followed by identification of the immune system responsible for it, 
provided sufficient information to rule out the possibility that the radiation chi-
meras analyzed in the present study had a tolerant immune system. This con-
clusion, however, need not conflict with the possibility that individual donor cells 
were tolerant. A smaller number of antibody-forming cells in the chimeras, 
compared to that in normal mice, may indeed account for the subnormal effi-
ciency of the chimera immune system to react against the heterologous antigen. 
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